Literature DB >> 2957834

T cell subsets and graft-versus-host disease.

R Korngold, J Sprent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957834     DOI: 10.1097/00007890-198709000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  32 in total

1.  FK506 augments activation-induced programmed cell death of T lymphocytes in vivo.

Authors:  K Migita; K Eguchi; Y Kawabe; T Tsukada; A Mizokami; S Nagataki
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

2.  Allogeneic and autologous bone-marrow transplantation.

Authors:  H J Deeg
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

Review 3.  Immune reconstitution following bone marrow transplantation.

Authors:  U N Verma; A Mazumder
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

4.  Sequential measurement of the murine acute-phase protein serum amyloid P component (SAP) as an indicator of graft-versus-host disease following allogeneic bone marrow transplantation in mice.

Authors:  K F Bayston; R Huby; J Cohen
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

Review 5.  Prevention of GVHD without losing GVL effect: windows of opportunity.

Authors:  Ping Zhang; Benny J Chen; Nelson J Chao
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 6.  T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients.

Authors:  K S Slobod; E Benaim; L Woodruff; S Nooner; J Houston; M Holladay; T Lockey; J L Hurwitz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

7.  The cellular basis of the local graft-versus-host reaction in rat kidney.

Authors:  E M Bolton; J A Gracie; L A O'Reilly; J A Bradley
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

8.  Subacute panencephalitis associated with chronic graft-versus-host disease.

Authors:  Y Iwasaki; K Sako; Y Ohara; M Miyazawa; M Minegishi; S Tsuchiya; T Konno
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 9.  Graft-versus-host disease after donor leukocyte infusions: presentation and management.

Authors:  Noelle V Frey; David L Porter
Journal:  Best Pract Res Clin Haematol       Date:  2008-06       Impact factor: 3.020

10.  Evaluation of in vitro cytotoxic T lymphocyte assays as a predictive test for the occurrence of graft vs host disease.

Authors:  P Fontaine; J Langlais; C Perreault
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.